Found: 20
Select item for more details and to access through your institution.
Epidemiologic patterns of biliary tract cancer in the United States: 2001–2015.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10286-z
- By:
- Publication type:
- Article
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 10, p. 1132, doi. 10.1093/jnci/djad121
- By:
- Publication type:
- Article
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 804, doi. 10.1634/theoncologist.2016-0415
- By:
- Publication type:
- Article
Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 15, p. 5406, doi. 10.1002/cam4.3229
- By:
- Publication type:
- Article
The Expression of PTEN Is Associated With Improved Prognosis in Patients With Ampullary Adenocarcinoma After Pancreaticoduodenectomy.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 11, p. 1619, doi. 10.5858/arpa.2012-0418-OA
- By:
- Publication type:
- Article
Biliary Cancer: Gateway to Comprehensive Molecular Profiling.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 1, p. 27
- By:
- Publication type:
- Article
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Next-generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Inhibition of the mammalian target of rapamycin(mTOR) in advanced pancreatic cancer: results oftwo phase II studies.
- Published in:
- BMC Cancer, 2010, v. 10, p. 368, doi. 10.1186/1471-2407-10-368
- By:
- Publication type:
- Article
Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3816, doi. 10.3390/cancers12123816
- By:
- Publication type:
- Article
New Treatment Options for Advanced Biliary Tract Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
COVID-19 Vaccines and Immunosuppressed Patients With Cancer: Critical Considerations.
- Published in:
- Clinical Journal of Oncology Nursing, 2022, v. 26, n. 4, p. 367, doi. 10.1188/22.CJON.367-373
- By:
- Publication type:
- Article
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0616-2
- By:
- Publication type:
- Article
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01246-2
- By:
- Publication type:
- Article
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
- Published in:
- British Journal of Cancer, 2018, v. 118, n. 2, p. e2, doi. 10.1038/bjc.2017.418
- By:
- Publication type:
- Article
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 11, p. 1402, doi. 10.1038/bjc.2017.119
- By:
- Publication type:
- Article
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article